IOVA — Iovance Biotherapeutics, Inc. - Common Stock
Session close: $14.45. Regular-session share volume: 71,841,302. Change from previous close: +31.48%.
News sources
Company news Iovance Biotherapeutics’ Amtagvi Demand Drives 2026 Revenue Guidance Bump, Stock Soars · Company news HC Wainwright & Co. Maintains Buy on Iovance Biotherapeutics, Raises Price Target to $20 · Company news CarMax Posts Upbeat Q2 Earnings, Joins Iovance Biotherapeutics, Perella Weinberg Partners And Other Big Stocks Moving Higher On Tuesday